ATE234093T1 - Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden - Google Patents

Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden

Info

Publication number
ATE234093T1
ATE234093T1 AT00400193T AT00400193T ATE234093T1 AT E234093 T1 ATE234093 T1 AT E234093T1 AT 00400193 T AT00400193 T AT 00400193T AT 00400193 T AT00400193 T AT 00400193T AT E234093 T1 ATE234093 T1 AT E234093T1
Authority
AT
Austria
Prior art keywords
alkyl
cycloalkyl
indolene
cyano
receptor ligands
Prior art date
Application number
AT00400193T
Other languages
English (en)
Inventor
Gilbert Lavielle
Olivier Muller
Bernard Cimetiere
Mark Millan
Alain Gobert
Jean-Michel Rivet
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE234093T1 publication Critical patent/ATE234093T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00400193T 1999-01-26 2000-01-26 Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden ATE234093T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900801A FR2788772B1 (fr) 1999-01-26 1999-01-26 Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE234093T1 true ATE234093T1 (de) 2003-03-15

Family

ID=9541208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00400193T ATE234093T1 (de) 1999-01-26 2000-01-26 Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden

Country Status (22)

Country Link
US (1) US6239129B1 (de)
EP (1) EP1023898B1 (de)
JP (1) JP2000212162A (de)
KR (1) KR100445389B1 (de)
CN (1) CN1155570C (de)
AT (1) ATE234093T1 (de)
AU (1) AU761084B2 (de)
BR (1) BR0000158A (de)
CA (1) CA2297279C (de)
DE (1) DE60001591T2 (de)
DK (1) DK1023898T3 (de)
EA (1) EA003146B1 (de)
ES (1) ES2193923T3 (de)
FR (1) FR2788772B1 (de)
HK (1) HK1029584A1 (de)
HU (1) HUP0000308A2 (de)
MX (1) MXPA00000856A (de)
NO (1) NO314801B1 (de)
NZ (1) NZ502494A (de)
PL (1) PL338027A1 (de)
SI (1) SI1023898T1 (de)
ZA (1) ZA200000336B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001247562A (ja) * 2000-03-07 2001-09-11 Daicel Chem Ind Ltd アミド化合物及びその製造方法
AU2426602A (en) * 2000-11-20 2002-05-27 Biovitrum Ab Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
WO2002079152A1 (en) 2001-03-29 2002-10-10 Bristol-Myers Squibb Company Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
NZ537982A (en) * 2002-09-17 2007-05-31 Hoffmann La Roche 2,7-substituted indoles and their use as 5-HT6 modulators
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
EP1689389A4 (de) * 2003-12-04 2009-06-17 Nat Health Research Institutes Indol-verbindungen
FR2884251B1 (fr) * 2005-04-08 2007-07-13 Servier Lab Derives de piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2015066344A1 (en) 2013-11-01 2015-05-07 Arena Pharmaceuticals, Inc. 5-ht2c receptor agonists and compositions and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK181190D0 (da) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-aryl-indol- eller 3-aryl-indazolderivater
TW270114B (de) * 1993-10-22 1996-02-11 Hoffmann La Roche
DE19500689A1 (de) * 1995-01-12 1996-07-18 Merck Patent Gmbh Indolpiperidin-Derivate
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
JP3560986B2 (ja) * 1997-01-13 2004-09-02 山之内製薬株式会社 5―ht2c受容体作用薬及びアミノアルキルインダゾール誘導体

Also Published As

Publication number Publication date
ES2193923T3 (es) 2003-11-16
NO314801B1 (no) 2003-05-26
CN1155570C (zh) 2004-06-30
FR2788772A1 (fr) 2000-07-28
US6239129B1 (en) 2001-05-29
DE60001591D1 (de) 2003-04-17
EA003146B1 (ru) 2003-02-27
SI1023898T1 (en) 2003-06-30
CA2297279C (fr) 2004-05-18
DE60001591T2 (de) 2003-12-24
EA200000068A3 (ru) 2000-10-30
HUP0000308A2 (en) 2002-06-29
DK1023898T3 (da) 2003-06-10
FR2788772B1 (fr) 2001-03-02
NO20000373D0 (no) 2000-01-25
MXPA00000856A (es) 2002-03-08
JP2000212162A (ja) 2000-08-02
EP1023898A1 (de) 2000-08-02
BR0000158A (pt) 2000-09-19
EA200000068A2 (ru) 2000-08-28
ZA200000336B (en) 2000-08-15
AU1355300A (en) 2000-07-27
AU761084B2 (en) 2003-05-29
HU0000308D0 (en) 2000-03-28
HK1029584A1 (en) 2001-04-06
EP1023898B1 (de) 2003-03-12
KR100445389B1 (ko) 2004-08-25
NO20000373L (no) 2000-07-27
PL338027A1 (en) 2000-07-31
NZ502494A (en) 2001-06-29
CN1266057A (zh) 2000-09-13
CA2297279A1 (fr) 2000-07-26
KR20010006587A (ko) 2001-01-26

Similar Documents

Publication Publication Date Title
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
RU2368608C2 (ru) Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
EA200601235A1 (ru) Производные тиазола
TNSN05069A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
ATE234093T1 (de) Cyano-indolen als serotoninwiederaufnahme inhibitoren und als 5-ht2c rezeptor liganden
ATE268767T1 (de) N-aryl-piperidinderivate und ihre verwendung als 5-ht1b-rezeptorliganden
AU9079198A (en) Indolecarboxylic compounds and their use as pharmaceutical compounds
ATE125808T1 (de) Indolederivate und ihre verwendung als serotonin- antagoniste.
ATE249457T1 (de) Indolderivate und ihre verwendung als serotoninrezeptor-liganden
ECSP930953A (es) Nuevos derivados de indol
DE60128239D1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
BR0208823A (pt) Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
KR960704878A (ko) 광학 활성 이미다졸리딘온 유도체 및 이의 제조방법 (Optically active imidazolidinone derivative and process for producing the same)
DK1161424T3 (da) Hidtil ukendte diazolderivater som serotonerge midler
DE69229845T2 (de) 2-Piperazinylbenzimidazolderivate
NO20002315L (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander
DK1140919T3 (da) 1,4-Disubstituerede cyclohexanderivater til behandling af depression
EP1325913A3 (de) Piperidincarbonsäuramid-Derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1023898

Country of ref document: EP

REN Ceased due to non-payment of the annual fee